Emerging Therapy, Unmet Needs and TPP Insights

Connect with Expert

Thelansis’s “Emerging Therapy Insights” report provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication.

Key outcomes:

  • What are the emerging therapies under development for the specific disease area in the G8 markets (US, EU5, Japan, China)?
  • What are the target patient groups and the analysis of clinical trials’ design?
  • What are the key primary and secondary endpoints, and expectations of KOLs from the therapies?
  • What is the probability of success for emerging therapies?
  • What are KOL expectations from emerging therapies to overcome the challenges of current therapies?
  • What would be the market share for studied TPPs for the specific disease area?

Reports:

October 16, 2024

Market Outlook and Forecast

Relapsed or Refractory Mycosis Fungoides (MF) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Relapsed or Refractory Mycosis Fungoides (MF) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Relapsed or Refractory Mycosis Fungoides treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 13, 2024

Market Outlook and Forecast

Amblyopia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Amblyopia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Amblyopia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 11, 2024

Market Outlook and Forecast

Phelan-McDermid Syndrome (PMS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Phelan-McDermid Syndrome (PMS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential 22q13 deletion syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 2, 2024

Market Outlook and Forecast

Lymphocytopenia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Lymphocytopenia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Lymphopenia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 18, 2024

Market Outlook and Forecast

Pericarditis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Pericarditis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Pericarditis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 5, 2024

Market Outlook and Forecast

Moderate to Severe Chronic Hand Eczema – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Moderate to Severe Chronic Hand Eczema Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Moderate to Severe Chronic Hand Eczema treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Explore Reports

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.

Connect with Expert